About us
Client Terms and Conditions
All Insource Purchase Orders are subject to our terms and conditions. Please see below links to each of our Terms and Conditions for your reference.
Main Terms and Conditions:
Supplementary Terms and Conditions:
- Insource Products Software Licence Agreement
- Insource Products End User Licence Agreement
- Fixed Price Contract SLA Supplementary T&Cs
- Time Materials SLA Supplementary T&Cs
- LEEP Support SLA Supplementary T&Cs
- Structured Training Course SLA Supplementary T&Cs
- Insource Data as a Service Terms and Conditions
- Insource Infrastructure Managed Services Terms and Conditions
- Standard Support Service Level Agreement
- Standard Support Plus Service Level Agreement
- Enhanced Support Service Level Agreement
- AppGuard License Managed Services Agreement
- Download our Carbon Reduction Plan
The term ‘Insource’ or ‘us’ or ‘we’ refers to Insource Ltd whose registered office is Insource House, 4 Southern Court, South Street, Reading, Berkshire, RG1 4QS. Our company registration number is 03835180, registered in England. The term ‘you’ refers to the user of our products or services.
We are DTAC compliant, our accreditations include:
At Insource we constantly strive for excellence and are proud of our achievements. Below are some of them:
Latest Insights
Beating cancer at scale with pathway transformation
The number of people diagnosed with cancer in the UK continues to grow and for the first time the number of annual new cases has passed 400,000. For many people, one of the most difficult parts of that journey is not the diagnosis itself, but the waiting that comes...
Wait list growth in April cancels out March ‘sprint’
The English referral-to-treatment (RTT) waiting list grew by 112,000 patient pathways in April, reversing the gains of March's 'sprint' and returning the list size to a little larger than it was at the end of February. Analysis produced for Health Service...
Target hit as unreported removals spike
At the end of March, the English NHS hit its interim target that 65% of the referral-to-treatment (RTT) waiting list should fall within 18 weeks, an achievement that NHS England are understandably very pleased about. Analysis produced for Health Service Journal by Dr...